{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:29:54Z","timestamp":1787506194149,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatic Heart Disease (RHD) is a disease of poverty that is neglected in developing countries, including South Africa. Lack of adequate evidence regarding the cost of RHD care has hindered national and international actions to prevent RHD related deaths. The objective of this study was to estimate the cost of RHD-related health services in a tertiary hospital in the Western Cape, South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The primary data on service utilisation were collected from a randomly selected sample of 100 patient medical records from the Global Rheumatic Heart Disease Registry (the REMEDY study) - a registry of individuals living with RHD. Patient-level clinical data, including, prices and quantities of medications and laboratory tests, were collected from the main tertiary hospital providing RHD care. All annual costs from a health system perspective were estimated in 2017 (base year) in South African Rand (ZAR) using a combination of ingredients and step-down costing approaches and later converted to United States dollars (USD). Step-down costing was used to estimate provider time costs and all other facility costs such as overheads. A 3% discount rate was also employed in order to allow depreciation and opportunity cost. We aggregated data to estimate the total annual costs and the average annual per-patient cost of RHD and conducted a one-way sensitivity analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The estimated total cost of RHD care at the tertiary hospital was USD 2 million (in 2017 USD) for the year 2017, with surgery costs accounting for 65%. Per-patient, average annual costs were USD 3900. For the subset of costs estimated using the ingredients approach, outpatient medications, and consumables related to cardiac catheterisation and heart valve surgery were the main cost drivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RHD-related healthcare consumes significant tertiary hospital resources in South Africa, with annual per-patient costs higher than many other non-communicable and infectious diseases. This analysis supports the scaling up of primary and secondary prevention programmes at primary health centers in order to reduce future tertiary care costs. The study could also inform resource allocation efforts and provide cost estimates for future studies of intervention cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-021-11314-6","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T09:02:29Z","timestamp":1625302949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Health system costs of rheumatic heart disease care in South Africa"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-844X","authenticated-orcid":false,"given":"Assegid G.","family":"Hellebo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl J.","family":"Zuhlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunke","family":"Alaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"issue":"1","key":"11314_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S1744133112000060","volume":"8","author":"JE Ataguba","year":"2013","unstructured":"Ataguba JE, McIntyre D. Who benefits from health services in South Africa? Health Econ Policy Law. 2013;8(1):21\u201346. https:\/\/doi.org\/10.1017\/S1744133112000060.","journal-title":"Health Econ Policy Law"},{"issue":"4","key":"11314_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2190\/HS.37.4.f","volume":"37","author":"L Gilson","year":"2007","unstructured":"Gilson L, McIntyre D. Post-apartheid challenges: household access and use of health care in South Africa. Int J Health Serv. 2007;37(4):673\u201391. https:\/\/doi.org\/10.2190\/HS.37.4.f.","journal-title":"Int J Health Serv"},{"issue":"35","key":"11314_CR3","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1080\/00036846.2015.1137549","volume":"48","author":"JE Ataguba","year":"2016","unstructured":"Ataguba JE. Assessing equitable health financing for universal health coverage: a case study of South Africa. Appl Econ. 2016;48(35):3293\u2013306. https:\/\/doi.org\/10.1080\/00036846.2015.1137549.","journal-title":"Appl Econ"},{"key":"11314_CR4","doi-asserted-by":"crossref","unstructured":"Watkins D, Zuhlke L, Engel M, Mayosi B. Rheumatic Fever: Neglected Again. Science (New York, N.Y.), 2009;324. 37.","DOI":"10.1126\/science.324.5923.37b"},{"issue":"11","key":"11314_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group a streptococcal diseases. Lancet Infect Dis. 2005;5(11):685\u201394. https:\/\/doi.org\/10.1016\/S1473-3099(05)70267-X.","journal-title":"Lancet Infect Dis"},{"key":"11314_CR6","doi-asserted-by":"crossref","unstructured":"Watkins D, Hasan B, Mayosi B, et al. Structural Heart Diseases. Cardiovascular, Respiratory, and Related Disorders. 2017;Chapter 11.","DOI":"10.1596\/978-1-4648-0518-9_ch11"},{"issue":"10053","key":"11314_CR7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545\u2013602. https:\/\/doi.org\/10.1016\/S0140-6736(16)31678-6.","journal-title":"Lancet."},{"issue":"Suppl 6","key":"11314_CR8","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1542\/peds.97.6.996","volume":"97","author":"R Snitcowsky","year":"1996","unstructured":"Snitcowsky R. Rheumatic fever prevention in industrializing countries: problems and approaches. Pediatrics. 1996;97(Suppl 6):996\u20138.","journal-title":"Pediatrics"},{"issue":"4","key":"11314_CR9","first-page":"643","volume":"137","author":"RK Kumar","year":"2013","unstructured":"Kumar RK, Tandon R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res. 2013;137(4):643\u201358.","journal-title":"Indian J Med Res"},{"key":"11314_CR10","doi-asserted-by":"crossref","unstructured":"Watkins D, Zuhlke L, Engel M, Daniels R, Francis V, Shaboodien G, et al. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqu\u00e9. Cardiovasc J Afr. 2016;27(3):184\u2013187.","DOI":"10.5830\/CVJA-2015-090"},{"key":"11314_CR11","doi-asserted-by":"publisher","unstructured":"Peter Zilla, Magdi Yacoub, Liesl Z\u00fchlke, Friedhelm Beyersdorf, Karen Sliwa, Gennadiy Khubulava, A Bouzid, AO Mocumbi, D Velayoudam, D Shetty, C Ofoegbu, A Geldenhuys, J Brink, J Scherman, H du Toit, S Hosseini, H Zhang, XJ Luo, W Wang, J Mejia, T Kofidis, RSD Higgins, J Pomar, RM Bolman, BM Mayosi, R Madansein, J Bavaria, AA Yanes-Quintana, AS Kumar, O Adeoye, RF Chauke, DF Williams Williams, Global Unmet Needs in Cardiac Surgery, Global Heart, Volume 13, Issue 4, 2018, 293\u2013303, DOI: https:\/\/doi.org\/10.1016\/j.gheart.2018.08.002.","DOI":"10.1016\/j.gheart.2018.08.002"},{"issue":"3 Pt 2","key":"11314_CR12","first-page":"246","volume":"96","author":"B Mayosi","year":"2006","unstructured":"Mayosi B, Robertson K, Volmink J, Adebo W, Akinyore K, Amoah A, et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J. 2006 Mar;96(3 Pt 2):246.","journal-title":"S Afr Med J"},{"issue":"18","key":"11314_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/eurheartj\/ehu449","volume":"36","author":"L Z\u00fchlke","year":"2015","unstructured":"Z\u00fchlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the global rheumatic heart disease registry (the REMEDY study). Eur Heart J. 2015;36(18):1115\u201322. https:\/\/doi.org\/10.1093\/eurheartj\/ehu449.","journal-title":"Eur Heart J"},{"issue":"2","key":"11314_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/heapol\/czh015","volume":"19","author":"L Conteh","year":"2004","unstructured":"Conteh L. Cost and unit cost calculations using step-down accounting. Health Policy Plan. 2004;19(2):127\u201335. https:\/\/doi.org\/10.1093\/heapol\/czh015.","journal-title":"Health Policy Plan"},{"issue":"1","key":"11314_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1478-7547-6-22","volume":"6","author":"T Adam","year":"2008","unstructured":"Adam T, Ebener S, Johns B, Evans DB. Capacity utilization and the cost of primary care visits: implications for the costs of scaling up health interventions. Cost Eff Resour Alloc. 2008;6(1):22. https:\/\/doi.org\/10.1186\/1478-7547-6-22.","journal-title":"Cost Eff Resour Alloc"},{"key":"11314_CR16","unstructured":"Cellini SR, Kee JE. Cost Effectiveness and Cost-Benefit Analysis. Handb Pract Progr Eval. 2010;:493\u2013530."},{"key":"11314_CR17","doi-asserted-by":"crossref","unstructured":"Cunnama L, Sinanovic E, Ramma L, Foster N, Berrie L, Stevens W, Molapo S, et al. Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale. Health Econ. 2016 Feb;25 Suppl 1(Suppl Suppl 1):53\u201366.","DOI":"10.1002\/hec.3295"},{"key":"11314_CR18","doi-asserted-by":"publisher","unstructured":"Afriandi I, Siregar AY, Meheus F, Hidayat T, van der Ven A, van Crevel R, et al. Costs of hospital-based methadone maintenance treatment in HIV\/AIDS control among injecting drug users in Indonesia. Health Policy (New York). 2010;95:69\u201373. doi:https:\/\/doi.org\/10.1016\/j.healthpol.2009.11.003.","DOI":"10.1016\/j.healthpol.2009.11.003"},{"issue":"10","key":"11314_CR19","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hec.1542","volume":"19","author":"S Cleary","year":"2010","unstructured":"Cleary S, Mooney G, McIntyre D. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting. Health Econ. 2010;19(10):1166\u201380. https:\/\/doi.org\/10.1002\/hec.1542.","journal-title":"Health Econ"},{"key":"11314_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/pmed.2002.1062","volume":"35","author":"J Ehrlich","year":"2020","unstructured":"Ehrlich J, Demopoulos BP, Daniel KR, Ricarte MC, Sherry G. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group a streptococcal pharyngitis in a paediatric population. Prev Med. 2020;35:250\u20137.","journal-title":"Prev Med"},{"key":"11314_CR21","doi-asserted-by":"crossref","unstructured":"Wang S, Petzold M, Cao J, Zhang Y, Wang W. Direct medical costs of hospitalizations for cardiovascular diseases in Shanghai, China: trends and projections. Medicine (Baltimore). 2015;94(20).","DOI":"10.1097\/MD.0000000000000837"},{"key":"11314_CR22","doi-asserted-by":"crossref","unstructured":"Watkins DA, Mvundura M, Nordet P, Mayosi BM. A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba. PLoS One. 2015;10.","DOI":"10.1371\/journal.pone.0121363"},{"issue":"7","key":"11314_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1747-4949.2012.00827.x","volume":"8","author":"M Hashmi","year":"2013","unstructured":"Hashmi M, Khan M, Wasay M. Growing burden of stroke in Pakistan: a review of progress and limitations. Int J Stroke. 2013 Oct;8(7):575\u201381. https:\/\/doi.org\/10.1111\/j.1747-4949.2012.00827.x.","journal-title":"Int J Stroke"},{"issue":"3","key":"11314_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCOUTCOMES.111.000032","volume":"6","author":"J Irlam","year":"2013","unstructured":"Irlam J, Mayosi BM, Engel M, Gaziano TA. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in south African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):343\u201351. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.111.000032.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"11314_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108304","volume":"9","author":"E Tagar","year":"2014","unstructured":"Tagar E, Sundaram M, Condliffe K, Matatiyo B, Chimbwandira F, Chilima B, et al. Multi-country analysis of treatment costs for HIV\/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia. PLoS One. 2014;9(11):e108304. https:\/\/doi.org\/10.1371\/journal.pone.0108304.","journal-title":"PLoS One"},{"issue":"7","key":"11314_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.5588\/ijtld.15.1001","volume":"20","author":"KG Castro","year":"2016","unstructured":"Castro KG, Marks SM, Chen MP, Hill AN, Becerra JE, Miramontes R, et al. Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades. Int J Tuberc Lung Dis. 2016;20(7):926\u201333. https:\/\/doi.org\/10.5588\/ijtld.15.1001.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11314_CR27","unstructured":"Hongoro DJ. The cost and cost-effectiveness of a text-messaging based intervention to support management of hypertension in South Africa. Mini-dissertation submitted to the University of Cape Town in partial fulfilment of the requirements for the Master of Public Health degree (Health Economics), 2017."},{"key":"11314_CR28","doi-asserted-by":"crossref","unstructured":"Naghavi MC, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet, 385(9963), 117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"issue":"10126","key":"11314_CR29","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0140-6736(17)32471-6","volume":"391","author":"D Prabhakaran","year":"2018","unstructured":"Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya JC. Nugent R; disease control Priorities-3 cardiovascular, respiratory, and related disorders author group. Cardiovascular, respiratory, and related disorders: key messages from disease control priorities, 3rd edition. Lancet. 2018;391(10126):1224\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(17)32471-6.","journal-title":"Lancet."},{"key":"11314_CR30","doi-asserted-by":"crossref","unstructured":"Rechner IJ, Lipman J. The costs of caring for patients in a tertiary referral Australian Intensive Care Unit. Anaesthesia Intensive Care. 2005;33. 477\u201382.","DOI":"10.1177\/0310057X0503300409"},{"key":"11314_CR31","doi-asserted-by":"publisher","unstructured":"Rechner IJ, Lipman J. The costs of caring for patients in a tertiary referral Australian intensive care unit. Anaesth Intensive Care 2005;33(4):477\u2013482. doi: https:\/\/doi.org\/10.1177\/0310057X0503300409. PMID: 16119489.","DOI":"10.1177\/0310057X0503300409"},{"key":"11314_CR32","unstructured":"Zilla P. Affordable heart valves to help rheumatic heart disease sufferers | UCT News, 2017. https:\/\/www.news.uct.ac.za\/article\/-2014-07-07-uct-designed-heart-valve-gives-hope-to-africa [Accesssed 12 Jan 2018]."},{"issue":"20","key":"11314_CR33","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134. 24141714. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11314-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11314-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11314-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T12:44:21Z","timestamp":1672663461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11314-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11314"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11314-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"11 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research is a sub-study of an existing study. The title of the bigger study is the Pan African Society of Cardiology Fever\/Rheumatic Heart Disease Prevention Programme in African Nations. (THE ASAP PROJECT-REC REF:028\/2006).Ethics approval was obtained from the Human Research Ethics Committee (HREC) of the University of Cape Town (UCT) (Ref: 436\/2017) as well as permission to access data from Groote Schuur Hospital was obtained from the Western Cape Department of Health (WCDH) prior to commencement of study. The research also complied with the World Medical Association Declaration of Helsinki on Ethical Principles for Research Involving Human Subjects [\n                      \n                      ].During the review of the medical records, privacy was maintained, and no identifying information such as patient participants\u2019 names and identity numbers were collected. In addition, the study has minimal risk as it only involves accessing adult participants records from the big study database of an existing study. This sub-study (Ref: 436\/2017) entails medical records reviews and extraction of data from hospital databases with no contact with patients as well as no identifying information of the patients. Data analyzed were confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1303"}}